126 related articles for article (PubMed ID: 22155860)
1. A novel screening biomarker in gastric cancer: serum Dickkopf-1.
Gomceli I; Bostanci EB; Ozer I; Kemik AS; Turhan N; Tez M; Kilic S; Demiriz B; Akoglu M
Hepatogastroenterology; 2012; 59(117):1661-4. PubMed ID: 22155860
[TBL] [Abstract][Full Text] [Related]
2. Mining the gastric cancer secretome: identification of GRN as a potential diagnostic marker for early gastric cancer.
Loei H; Tan HT; Lim TK; Lim KH; So JB; Yeoh KG; Chung MC
J Proteome Res; 2012 Mar; 11(3):1759-72. PubMed ID: 22204653
[TBL] [Abstract][Full Text] [Related]
3. Plasma matrix metalloproteinase-9 level is better than serum matrix metalloproteinase-9 level to predict gastric cancer evolution.
Wu CY; Wu MS; Chiang EP; Chen YJ; Chen CJ; Chi NH; Shih YT; Chen GH; Lin JT
Clin Cancer Res; 2007 Apr; 13(7):2054-60. PubMed ID: 17404086
[TBL] [Abstract][Full Text] [Related]
4. Serum TIMP-1 in gastric cancer patients: a potential prognostic biomarker.
Wang CS; Wu TL; Tsao KC; Sun CF
Ann Clin Lab Sci; 2006; 36(1):23-30. PubMed ID: 16501233
[TBL] [Abstract][Full Text] [Related]
5. Assessment of circulating Dickkopf-1 with a new two-site immunoassay in healthy subjects and women with breast cancer and bone metastases.
Voorzanger-Rousselot N; Journe F; Doriath V; Body JJ; Garnero P
Calcif Tissue Int; 2009 May; 84(5):348-54. PubMed ID: 19252761
[TBL] [Abstract][Full Text] [Related]
6. Clinical significance of serum Dkk-3 in patients with gynecological cancer.
Jiang T; Huang L; Wang S; Zhang S
J Obstet Gynaecol Res; 2010 Aug; 36(4):769-73. PubMed ID: 20666943
[TBL] [Abstract][Full Text] [Related]
7. Promoter methylation of the Wnt/beta-catenin signaling antagonist Dkk-3 is associated with poor survival in gastric cancer.
Yu J; Tao Q; Cheng YY; Lee KY; Ng SS; Cheung KF; Tian L; Rha SY; Neumann U; Röcken C; Ebert MP; Chan FK; Sung JJ
Cancer; 2009 Jan; 115(1):49-60. PubMed ID: 19051296
[TBL] [Abstract][Full Text] [Related]
8. Elevated levels of serum and plasma metalloproteinases in patients with gastric cancer.
Endo K; Maehara Y; Baba H; Yamamoto M; Tomisaki S; Watanabe A; Kakeji Y; Sugimachi K
Anticancer Res; 1997; 17(3C):2253-8. PubMed ID: 9216697
[TBL] [Abstract][Full Text] [Related]
9. Serum hyaluronic acid and laminin as potential tumor markers for upper gastrointestinal cancers.
Aghcheli K; Parsian H; Qujeq D; Talebi M; Mosapour A; Khalilipour E; Islami F; Semnani S; Malekzadeh R
Eur J Intern Med; 2012 Jan; 23(1):58-64. PubMed ID: 22153533
[TBL] [Abstract][Full Text] [Related]
10. Serum HDL-C as a potential biomarker for nodal stages in gastric cancer.
Guo E; Chen L; Xie Q; Chen J; Tang Z; Wu Y
Ann Surg Oncol; 2007 Sep; 14(9):2528-34. PubMed ID: 17597347
[TBL] [Abstract][Full Text] [Related]
11. Plasma adiponectin and gastric cancer.
Ishikawa M; Kitayama J; Kazama S; Hiramatsu T; Hatano K; Nagawa H
Clin Cancer Res; 2005 Jan; 11(2 Pt 1):466-72. PubMed ID: 15701829
[TBL] [Abstract][Full Text] [Related]
12. Overexpression of minichromosome maintenance 2 predicts poor prognosis in patients with gastric cancer.
Yang C; Wen Y; Li H; Zhang D; Zhang N; Shi X; Jiang B; Ma X; Yang P; Tang H; Peng Z; Yang Y
Oncol Rep; 2012 Jan; 27(1):135-42. PubMed ID: 21947329
[TBL] [Abstract][Full Text] [Related]
13. Adenocarcinoma in the middle third of the stomach--an evaluation for the prognostic significance of clinicopathological features.
Sheen-Chen SM; Chou CW; Chen MC; Chen FC; Chen YS; Chen JJ
Hepatogastroenterology; 1997; 44(17):1488-94. PubMed ID: 9356878
[TBL] [Abstract][Full Text] [Related]
14. Receiver operating characteristic (ROC) curve analysis of the tumor markers CEA, CA 19-9 and CA 72-4 in gastric cancer.
Fernández-Fernández L; Tejero E; Tieso A; Rabadán L; Munoz M; Santos I
Int Surg; 1996; 81(4):400-2. PubMed ID: 9127805
[TBL] [Abstract][Full Text] [Related]
15. Serum Dickkopf-1 levels as a clinical and prognostic factor in patients with bladder cancer.
Sun DK; Wang L; Wang JM; Zhang P
Genet Mol Res; 2015 Dec; 14(4):18181-7. PubMed ID: 26782465
[TBL] [Abstract][Full Text] [Related]
16. Soluble E-cadherin is an independent pretherapeutic factor for long-term survival in gastric cancer.
Chan AO; Chu KM; Lam SK; Wong BC; Kwok KF; Law S; Ko S; Hui WM; Yueng YH; Wong J
J Clin Oncol; 2003 Jun; 21(12):2288-93. PubMed ID: 12805328
[TBL] [Abstract][Full Text] [Related]
17. Identification of 14-3-3β in human gastric cancer cells and its potency as a diagnostic and prognostic biomarker.
Tseng CW; Yang JC; Chen CN; Huang HC; Chuang KN; Lin CC; Lai HS; Lee PH; Chang KJ; Juan HF
Proteomics; 2011 Jun; 11(12):2423-39. PubMed ID: 21598387
[TBL] [Abstract][Full Text] [Related]
18. Is there any impact of plasma M30 and M65 levels on progression-free survival of patients with advanced gastric cancer?
Bilici A; Ustaalioglu BB; Ercan S; Orcun A; Seker M; Salepci T; Gumus M
Cancer Chemother Pharmacol; 2011 Aug; 68(2):309-16. PubMed ID: 20967544
[TBL] [Abstract][Full Text] [Related]
19. Serum angiopoietin-like protein 2 as a potential biomarker for diagnosis, early recurrence and prognosis in gastric cancer patients.
Toiyama Y; Tanaka K; Kitajima T; Shimura T; Imaoka H; Mori K; Okigami M; Yasuda H; Okugawa Y; Saigusa S; Ohi M; Inoue Y; Mohri Y; Goel A; Kusunoki M
Carcinogenesis; 2015 Dec; 36(12):1474-83. PubMed ID: 26420253
[TBL] [Abstract][Full Text] [Related]
20. Netrin-1 concentrations in patients with advanced gastric cancer and its relation with treatment.
Kefeli U; Yildirim ME; Aydin D; Madenci OC; Yasar N; Sener N; Mert AG; Yuksel S; Ercelep OB; Korkmaz T; Yildiz R; Gumus M
Biomarkers; 2012 Nov; 17(7):663-7. PubMed ID: 22889408
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
